Bourg, N.; Vu Hong, A.; Lostal, W.; Jaber, A.; Guerchet, N.; Tanniou, G.; Bordier, F.; Bertil-Froidevaux, E.; Georger, C.; Daniele, N.;
et al. Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy. Int. J. Mol. Sci. 2022, 23, 2016.
https://doi.org/10.3390/ijms23042016
AMA Style
Bourg N, Vu Hong A, Lostal W, Jaber A, Guerchet N, Tanniou G, Bordier F, Bertil-Froidevaux E, Georger C, Daniele N,
et al. Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy. International Journal of Molecular Sciences. 2022; 23(4):2016.
https://doi.org/10.3390/ijms23042016
Chicago/Turabian Style
Bourg, Nathalie, Ai Vu Hong, William Lostal, Abbass Jaber, Nicolas Guerchet, Guillaume Tanniou, Fanny Bordier, Emilie Bertil-Froidevaux, Christophe Georger, Nathalie Daniele,
and et al. 2022. "Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy" International Journal of Molecular Sciences 23, no. 4: 2016.
https://doi.org/10.3390/ijms23042016
APA Style
Bourg, N., Vu Hong, A., Lostal, W., Jaber, A., Guerchet, N., Tanniou, G., Bordier, F., Bertil-Froidevaux, E., Georger, C., Daniele, N., Richard, I., & Israeli, D.
(2022). Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy. International Journal of Molecular Sciences, 23(4), 2016.
https://doi.org/10.3390/ijms23042016